Dr. Kelly G. Paulson

"Dr. Paulson is passionate about practicing medical oncology, as it seamlessly integrates cutting-edge scientific advancements with the compassionate essence of medicine. Her clinical interests focus on skin cancer and solid tumor immunotherapy while Dr. Paulson’s appreciation lies in the ability to establish meaningful connections with patients and their families, throughout their care. Dr. Paulson firmly believes that optimal cancer care is achieved through a collaborative, team-based approach and takes great joy in working alongside an interdisciplinary team of dedicated healthcare professionals. Recognizing the pivotal role of patients in their own care, she is committed to transparent communication, ensuring that everyone understands the ""how and why"" behind their personalized treatment plans. In addition to her clinical role, Dr. Paulson is a skilled clinical researcher, serving as the Principal Investigator for various clinical trials aimed at bringing the latest advancements in cancer care and the lead for the Center for Immuno-Oncology at the Paul G Allen Research Center. Furthermore, she is dedicated to nurturing the next generation of medical professionals, actively supporting medical students at the Washington State University Elson E. Floyd Medical School in Everett, particularly in advancing their understanding of emerging immunotherapies. In 2023, Dr. Kelly Paulson was honored as the inaugural recipient of the Jeff Ward Award, established to memorialize him. This distinguished award acknowledges medical staff members who contribute positively to the Edmonds community through exceptional leadership, mentorship, or improvements in patient care. Also, she is a 2024 Castle Connolly Top Doctor. Dr. Paulson sees patients at the Edmonds and First Hill Swedish Cancer Institute locations.".

Dr. Paulson is rated as an Experienced provider by MediFind in the treatment of Agranulocytosis. Her top areas of expertise are Merkel Cell Carcinoma, Neuroendocrine Tumor, Small Cell Lung Cancer (SCLC), and Colorectal Cancer.

Her clinical research consists of co-authoring 54 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.